Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value: $2.023B (100.0% shares, 0.0% debt)

Holdings (46)

UTHR UNITED THERAPEUTICS CORP DEL 12.2%
Value $247M Shares 1,429,928 Est. Cost $77.14 Unrealized +97.6%
BMRN BIOMARIN PHARMACEUTICAL INC 10.2%
Value $206M Shares 1,649,792 Est. Cost $73.11 Unrealized +44.9%
ANACOR PHARMACEUTICALS INC 9.3%
Value $189M Shares 3,259,045 Est. Cost $23.70 Unrealized
ABIOMED INC 8.8%
Value $177M Shares 2,473,624 Est. Cost $21.84 Unrealized
CLOVIS ONCOLOGY INC 7.8%
Value $158M Shares 2,121,857 Est. Cost $47.24 Unrealized
AMAG PHARMACEUTICALS INC 5.9%
Value $120M Shares 2,187,041 Est. Cost $28.67 Unrealized
THORATEC CORP 5.3%
Value $106M Shares 2,538,203 Est. Cost $40.89 Unrealized
INSM INSMED INC 4.8%
Value $96.71M Shares 4,649,448 Est. Cost $14.64 Unrealized +20.3%
ENDO INTL PLC 3.8%
Value $77.16M Shares 860,204 Est. Cost $89.70 Unrealized
KYTHERA BIOPHARMACEUTICALS I 3.4%
Value $69.34M Shares 1,382,722 Est. Cost $40.00 Unrealized
WRIGHT MED GROUP INC 2.6%
Value $52.87M Shares 2,049,251 Est. Cost $28.27 Unrealized
SEQUENOM INC 1.9%
Value $39.41M Shares 9,977,642 Est. Cost $3.91 Unrealized
VNDA VANDA PHARMACEUTICALS INC 1.7%
Value $35.37M Shares 3,803,408 Est. Cost $8.33 Unrealized +35.7%
KARYOPHARM THERAPEUTICS INC 1.4%
Value $29.11M Shares 951,032 Est. Cost $30.61 Unrealized
CELGENE CORP 1.4%
Value $28.75M Shares 249,400 Est. Cost $95.80 Unrealized
GILD GILEAD SCIENCES INC 1.4%
Value $28.56M Shares 291,000 Est. Cost $62.00 Unrealized +13.8%
CELLADON CORP 1.4%
Value $27.37M Shares 1,445,100 Est. Cost $12.12 Unrealized
CYBERONICS INC 1.3%
Value $26.75M Shares 412,000 Est. Cost $52.15 Unrealized
PRTA PROTHENA CORP PLC 1.3%
Value $26.54M Shares 695,918 Est. Cost $22.18 Unrealized +15.6%
SHIRE PLC 1.1%
Value $22.73M Shares 95,000 Est. Cost $228.93 Unrealized
MEDIVATION INC 1.1%
Value $22.16M Shares 171,700 Est. Cost $85.24 Unrealized
MOMENTA PHARMACEUTICALS INC 1.1%
Value $22.12M Shares 1,455,176 Est. Cost $14.44 Unrealized
HEARTWARE INTL INC 1.1%
Value $21.4M Shares 243,868 Est. Cost $87.77 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.1%
Value $21.29M Shares 1,956,376 Est. Cost $3.07 Unrealized +186.8%
STAA STAAR SURGICAL CO 1.0%
Value $19.64M Shares 2,642,922 Est. Cost $8.11 Unrealized -9.9%
RIGEL PHARMACEUTICALS INC 0.9%
Value $18.48M Shares 5,176,319 Est. Cost $3.43 Unrealized
ARIAD PHARMACEUTICALS INC 0.9%
Value $18.39M Shares 2,231,717 Est. Cost $6.82 Unrealized
ZELTIQ AESTHETICS INC 0.9%
Value $17.52M Shares 568,436 Est. Cost $26.16 Unrealized
INTUITIVE SURGICAL INC 0.8%
Value $16.34M Shares 32,350 Est. Cost $447.59 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.7%
Value $15.17M Shares 282,057 Est. Cost $53.35 Unrealized +6.8%
OREXIGEN THERAPEUTICS INC 0.7%
Value $15.12M Shares 1,931,324 Est. Cost $6.46 Unrealized
ALIMERA SCIENCES INC 0.7%
Value $15.1M Shares 3,013,793 Est. Cost $4.88 Unrealized
EXAS EXACT SCIENCES CORP 0.4%
Value $8.647M Shares 392,676 Est. Cost $12.83 Unrealized +97.7%
ACELRX PHARMACEUTICALS INC 0.4%
Value $8.244M Shares 2,135,739 Est. Cost $5.78 Unrealized
HISTOGENICS CORP 0.2%
Value $4.541M Shares 454,545 Est. Cost $11.00 Unrealized
IDERA PHARMACEUTICALS INC 0.2%
Value $4.342M Shares 1,170,248 Est. Cost $3.71 Unrealized
XOMA CORP DEL 0.1%
Value $2.892M Shares 794,500 Est. Cost $4.07 Unrealized
INTREXON CORP 0.1%
Value $2.137M Shares 47,100 Est. Cost $28.82 Unrealized
BIOSPECIFICS TECHNOLOGIES CO 0.1%
Value $1.975M Shares 50,436 Est. Cost $34.45 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $1.478M Shares 603,400 Est. Cost $2.45 Unrealized
QLT INC 0.1%
Value $1.235M Shares 315,906 Est. Cost $4.40 Unrealized
SALIX PHARMACEUTICALS INC 0.0%
Value $916K Shares 5,300 Est. Cost $114.94 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value $839K Shares 123,686 Est. Cost $6.71 Unrealized +11.2%
MALLINCKRODT PUB LTD CO 0.0%
Value $454K Shares 3,588 Est. Cost $90.02 Unrealized
ALCOBRA LTD 0.0%
Value $412K Shares 73,188 Est. Cost $5.63 Unrealized
SOPHIRIS BIO INC 0.0%
Value $111K Shares 191,600 Est. Cost $3.88 Unrealized